{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 477236893
| IUPAC_name = ''N''-[4-[2-(2,4-dimethylphenoxy)phenyl]-1,3-thiazol-2-yl]-1,4,5,6-tetrahydropyrimidin-2-amine
| image = Abafungin.svg
| alt = Structural formula of abafungin
| width = 175
| image2 = Abafungin 3D spacefill.png
| alt2 = Space-filling model of the abafungin molecule
| width2 = 150

<!--Clinical data-->
| tradename = Abasol
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration = Topical ([[Cream (pharmaceutical)|cream]])

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 129639-79-8
| ATC_prefix = none
| ATC_suffix =  
| ATC_supplemental =  
| PubChem = 159326
| ChEBI_Ref = {{ebicite|changed|EBI}}
| ChEBI = 76005
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 140124
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 11DI31LWXF

<!--Chemical data-->
| chemical_formula =  
| C=21 | H=22 | N=4 | O=1 | S=1 
| molecular_weight = 378.491 g/mol
| smiles = CC1=CC(=C(C=C1)OC2=CC=CC=C2C3=CSC(=N3)NC4=NCCCN4)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C21H22N4OS/c1-14-8-9-18(15(2)12-14)26-19-7-4-3-6-16(19)17-13-27-21(24-17)25-20-22-10-5-11-23-20/h3-4,6-9,12-13H,5,10-11H2,1-2H3,(H2,22,23,24,25)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = TYBHXIFFPVFXQW-UHFFFAOYSA-N
}}

'''Abafungin''' ([[International Nonproprietary Name|INN]]) is a broad-spectrum [[antifungal agent]] with a novel mechanism of action for the treatment of [[dermatomycoses]].

'''Abasol''' is a topical cream formulation of abafungin by [[York Pharma]].<ref>[http://www.yorkpharma.com/media/YRK-Update_Abasol_061002-FN.pdf York Pharma: Regulatory Update – Abasol] {{webarchive |url=https://web.archive.org/web/20070927102715/http://www.yorkpharma.com/media/YRK-Update_Abasol_061002-FN.pdf |date=September 27, 2007 }}</ref>

==Mechanism of action==
Unlike [[imidazole]]- and [[triazole]]-class antifungals, abafungin directly impairs the fungal cell membrane.<ref>Borelli C1, Schaller M, Niewerth M, Nocker K, Baasner B, Berg D, Tiemann R, Tietjen K, Fugmann B, Lang-Fugmann S, Korting HC. "Modes of action of the new arylguanidine abafungin beyond interference with ergosterol biosynthesis and in vitro activity against medically important fungi". Chemotherapy. 2008;54(4):245-59</ref>

In addition, abafungin inhibits the enzyme [[sterol 24-C-methyltransferase]], modifying the composition of the fungal membrane.<ref>Borelli C1, Schaller M, Niewerth M, Nocker K, Baasner B, Berg D, Tiemann R, Tietjen K, Fugmann B, Lang-Fugmann S, Korting HC. "Modes of action of the new arylguanidine abafungin beyond interference with ergosterol biosynthesis and in vitro activity against medically important fungi". Chemotherapy. 2008;54(4):245-59</ref>

Abafungin has antibiotic activity against [[gram-positive bacteria]] as well as [[Spore|sporicidal]] activity.<ref>{{citation|last=Ginter-Hanselmayer|first=Gabriele|date=March 2009|title=Arbeitsunterlagen zur 42. wissenschaftlichen Fortbildungsveranstaltung für Apothekerinnen und Apotheker: Infektionskrankheiten|publisher=Österreichische Apothekerkammer|page=103}}</ref>

==References==
{{reflist}}

{{antifungals}}

[[Category:Antifungals]]
[[Category:Thiazoles]]
[[Category:Phenol ethers]]
[[Category:Pyrimidines]]

{{antimicrobial-stub}}